What have mast cells to do with edema formation, the consecutive repair and fibrinolysis?

International Archives of Allergy and Immunology

Volumn 115, Issue 1, 1998, Pages 2-8

  Valent, Peter ^a   Sillaber, Christian ^b   Baghestanian, Mehrdad ^a   Bankl, Hans C ^b   Kiener, Hans P ^a   Lechner, Klaus ^a   Binder, Bernd R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

c kit; Fibrinolysis; Heparin; Mast cells; Plasminogen activator inhibitor; Repair; Stem cell factor; Tissue type plasminogen activator

Indexed keywords

HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATOR INHIBITOR 3; STEM CELL FACTOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE RECEPTOR;

EDEMA; FIBRINOLYSIS; MAST CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; EDEMA; FIBRINOGEN; HEPARIN; HUMANS; MAST CELLS; MICE; PLASMINOGEN INACTIVATORS; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL FACTOR; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0031964776     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023823     Document Type: Review

References (50)

1. Galli SJ: Biology of disease: New insights into 'the riddle of the mast cells': Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990;62:5-33.
2. Schwartz LB: The mast cell, in Kaplan AP (ed): Allergy. Edinburgh. Churchill Livingston, 1985, vol 1, pp 53-92.
3. Lewis RA, Austen KF: Mediation of homeostasis and inflammation by leukotrienes and other mast cell dependent compounds. Nature 1981; 293:103-108.
4. Serafin WE, Austen KF: Mediators of immediate hypersensitivity reactions. N Engl J Med 1987;317:30-34.
5. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME: Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989;170:245-257.
6. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF: Human dermal mast cells contain and release tumor necrosis factor a, which induces endothelial leucocyte adhesion molecule 1. Proc Natl Acad Sci (USA) 1991;88: 4220-4224.
7. Klein LM, Lavker RM, Matis WL, Murphy GF: Degranulation of human mast cells induces an endothelial cell antigen central to leukocyte adhesion. Proc Natl Acad Sci USA 1989;86: 8972-8976.
8. Wypij DM, Nochols SJ, Novak PJ, Stacy DL, Berman J, Wisman SJ: Role of mast cell chymase in the extracellular processing of big-endothelin-1 into endothelin-1 in the perfused rat lung. Biochem Pharmacol 1992:43:845-853.
9. Proctor GB, Chan KM, Garrett JR, Smith RE: Proteinase activities in bovine atrium and the possible role of mast cell tryptase in the processing of atrial natriuretic factor (ANF). Comp Biochem Physiol 1991;99:839-844.
10. Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM, Husain A: Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993;91:1269-1281.
11. Yano H, Wershil BK, Arizono N, Galli SJ: Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell-dependent. J Clin Invest 1989;84:1276-1286.
12. Zhang Y, Ramos BF, Jakschik BA: Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992;258:1957-1959.
13. Malaviya R, Ikeda T, Ross E, Abraham SN: Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996;381:77-80.
14. Mekori YA, Galli SJ: [125]fibrin deposition occurs at both early and late intervals of IgE-de-pendent or contact sensitivity reactions elicited in mouse skin. Mast cell-dependent augmentation of fibrin deposition at early intervals in combined IgE-dependent and contact sensitivity reactions. J Immunol 1990;145:3719-3727.
15. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol 1987;139:2605-2614.
16. Dvorak AM: Granule changes of human skin mast cells characteristic of piecemeal degranulation and association with recovery during wound healing in situ. J Leukoc Biol 1991;49: 197-210.
17. Norrby K: Mast cells and de novo angiogenesis: Angiogenic capability of individual mast cell mediators such as histamine, TNF, IL-8, and bFGF. Inflamm Res 1997;46(suppl 1):S7-S8.
18. Yurt RW, Leid RW, Austen KF, Silbert JE: Native heparin from rat peritoneal mast cells. J Biol Chem 1977;252:518-521.
19. Irani AA, Schlechter NM, Craig SS, DeBlois G, Schwartz LB: Two human mast cell subsets with distinct neutral protease compositions. Proc Natl Acad Sci USA 1984;83:4464-4468.
20. Schwartz LB, Badford TR, Littman BH, Wintroub BU: The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 1985;135:2762-2767.
21. Stack MS, Johnson DA: Human mast cell tryptase activates single chain urinary-type plasminogen activator (pro-urokinase). J Biol Chem 1994;269:9416-9419.
22. Pejler G, Karlstrom A: Thrombin is inactivated by mast cell secretory granule chymase. J Biol Chem 1993;268:11817-11822.
23. Sakai K, Ren S, Schwartz LB: A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. J Clin Invest 1996;97: 895-896.
24. Stein PL, van-Zonneveld AJ, Pannekock H, Strickland S: Structural domains of human tissue type plasminogen activator that confer stimulation by heparin. J Biol Chem 1989;264: 15441-15444.
25. Yamamoto C, Kaji T, Sakamoto M, Kozuka H, Koizumi F: Calcium regulation of tissue type plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells. Thromb Res 1994;74: 163-168.
26. Collen D, Lijnen HR: Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78:3114-3124.
27. Vassalli JD, Sappino AP, Belin D: The plasminogen activator/plasmin system. J Clin Invest 1991;88:1067-1072.
28. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994;368:419-424.
29. Bartholomew JS, Woolley DE: Plasminogen activator release from cultured murine mast cells. Biochem Biophys Res Commun 1988; 153:540-544.
30. SillaberC, Baghestanian M, Bevec D, Willheim M, Agis H, Kapiotis S, Füreder W, Bankl HC, Kiener H, Speiser W, Binder BR, Lechner K, Valent P: Mast cells as site of tissue type plasminogen activator production and fibrinolysis, submitted.
31. Bankl HC, Radaszkiewicz T, Baghestanian M, Mherabi MR, Bankl H, Lechner K, Valent P: Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosis. Hum Pathol, in press.
32. Sillaber C, Baghestanian M, Hofbauer R, Virgolini I, Bankl HC, Füreder W, Agis H, Willheim M, Leimer M, Scheiner O, Binder BR, Kiener H, Bevec D, Fritsch G, Majdic O, Kress HG, Gadner H, Lechner K, Valent P: Molecular and functional characterization of the urokinase receptor on human mast cells. J Biol Chem 1997;272:7824-7832.
33. Kruithof EKO: Plasminogen activator inhibitors a review. Enzyme 1988;40:113-121.
34. Malone DG, Wilder RL, Saavedra Delgado AM, Metcalfe DD: Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy. Arthritis Rheum 1987;30:130-137.
35. v mutant mice to brain thromboembolism and mortality caused by intravenous injection of india ink. Am J Pathol 1986;122:469-480.
36. Bankl HC, Radaszkiewicz T, Klappacher GW, Glogar D, Sperr WR, Grossschmidt K, Bankl H, Lechner K, Valent P: Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit ligand. Circulation 1995; 91:275-283.
37. Bankl HC, Valent P: Mast cells and mast cell growth factor: Possible role in auricular thrombosis. Biomed Rev 1995;4:29-32.
38. Bankl HC, Radaszkiewicz T, Baghestanian M, Mherabi MR, Bankl H, Kapiotis S, Hofbauer R, Lechner K, Valent P: Mast cells increase in number in deep venous thrombosis and express a pro-fibrinolytic phenotype, in preparation.
39. Valent P: The riddle of the mast cell: c-kit ligand as missing link? Immunol Today 1994;15:111-114.
40. Irani AM, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, Zsebo KM, Schwartz LB: Recombinant human stem cell factor stimulates differentiation of human mast cells from dispersed fetal liver cells. Blood 1992;80: 3009-3016.
41. Mitsui H, Furitsu T, Dvorak AM, Irani AM, Schwartz LB, Inagaki N, Takei M, Ishizaka K, Zsebo KM, Gillis S: Development of human mast cells from umbilical cord blood cells by recombinant human and murinc c-kit ligand. Proc Natl Acad Sci USA 1990;90:735 739.
42. Valent P, Spanblöchl E, Sperr WR, Sillaber Ch, Agis H, Zsebo K, Geissler K, Bettelheim P, Lechner K: Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (SCF)/kit ligand (KL) in long-term culture. Blood 1992;80:2237-2245.
43. Bischoff SC, Dahinden CA: c-kit ligand: A unique potentiator of mediator release by human lung mast cells. J Exp Med 1992;175:237-244.
44. Sperr WR, Czerwenka K, Mundigler G, Müller MR, Semper H, Klappacher G, Glogar D, Lechner K, Valent P: Specific activation of human mast cells by the ligand for c-kit: Comparison between lung-, uterus- and heart mast cells, Int Arch Allergy Appl Immunol 1993;102:170-175.
45. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A: Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994;153:3717-3723.
46. Baghestanian M, Hofbauer R, Kress HG, Wojta J, Fabry A, Binder BR, Kaun C, Müller MR, Mehrabi MR, Kapiotis S, Sengoelge G, Ghannadan M, Lechner K, Valent P: Thrombin augments vascular cell-dependent migration of human mast cells: Role of MGF. Thromb Haemost 1997;77:577-584.
47. Valent P, Bettelheim P: Cell surface structures on human basophils and mast cells: Biochemical and functional characterization. Adv Immunol 1992;52:333-423.
48. Sillaber Ch, Bevcc D, Asham LK, Butterfield JH, Lechner K, Maurer D, Bettelheim P, Valent P: IL-4 regulates c-kit gene product expression in human myeloid- and mast cell progenitors. J Immunol 1991;147:4224-4228.
49. Adachi S, Tsujimura T, Jippo T, Morimoto M, Isozaki K, Kasugai T, Nomura S, Kitamura Y: Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem cell factor. Exp Hematol 1995;23:58-65.
50. Baghestanian M, Hofbauer R, Kiener H-P, Bevec D, Agis H, Willheim M, Scheiner O, Füreder W, Müller MR, Kress HG, Lechner K, Valent P: The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein 1 (MCP-1) in human lung mast cells. Blood, in press.